Torrent Pharmaceuticals Limited (BOM:500420)
India
· Delayed Price · Currency is INR 4,370.80
+62.75 (1.46%)
At close: Mar 9, 2026
Torrent Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,479,277 | 1,094,736 | 880,347 | 520,309 | 473,197 | 430,029 | Upgrade
|
| Market Cap Growth | 42.15% | 24.35% | 69.20% | 9.96% | 10.04% | 28.90% | Upgrade
|
| Enterprise Value | 1,499,557 | 1,113,646 | 917,337 | 553,029 | 510,577 | 476,479 | Upgrade
|
| Last Close Price | 4370.80 | 3206.49 | 2553.21 | 1490.09 | 1331.89 | 1192.86 | Upgrade
|
| PE Ratio | 65.12 | 57.28 | 53.15 | 41.78 | 60.89 | 34.35 | Upgrade
|
| Forward PE | 88.77 | 43.21 | 43.79 | 35.81 | 31.03 | 34.20 | Upgrade
|
| PS Ratio | 11.61 | 9.51 | 8.21 | 5.41 | 5.56 | 5.37 | Upgrade
|
| PB Ratio | 17.51 | 14.42 | 12.84 | 8.40 | 7.95 | 7.37 | Upgrade
|
| P/TBV Ratio | 36.38 | 36.63 | 45.49 | 67.48 | 22.04 | 28.47 | Upgrade
|
| P/FCF Ratio | - | 55.48 | 31.07 | 29.00 | 29.57 | 25.75 | Upgrade
|
| P/OCF Ratio | - | 42.35 | 26.95 | 21.97 | 26.25 | 21.44 | Upgrade
|
| PEG Ratio | 4.32 | 1.90 | 1.82 | 1.94 | 2.34 | 2.11 | Upgrade
|
| EV/Sales Ratio | 11.77 | 9.67 | 8.55 | 5.75 | 6.00 | 5.95 | Upgrade
|
| EV/EBITDA Ratio | 36.34 | 30.30 | 27.59 | 19.73 | 21.43 | 19.62 | Upgrade
|
| EV/EBIT Ratio | 44.70 | 38.06 | 35.66 | 25.84 | 28.86 | 26.14 | Upgrade
|
| EV/FCF Ratio | - | 56.44 | 32.38 | 30.82 | 31.90 | 28.53 | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.43 | 0.59 | 0.87 | 0.69 | 0.84 | Upgrade
|
| Debt / EBITDA Ratio | 0.68 | 0.88 | 1.21 | 1.92 | 1.70 | 2.00 | Upgrade
|
| Debt / FCF Ratio | - | 1.65 | 1.43 | 3.02 | 2.57 | 2.95 | Upgrade
|
| Net Debt / Equity Ratio | 0.24 | 0.34 | 0.44 | 0.76 | 0.59 | 0.72 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.49 | 0.70 | 0.91 | 1.67 | 1.48 | 1.73 | Upgrade
|
| Net Debt / FCF Ratio | - | 1.30 | 1.07 | 2.62 | 2.20 | 2.51 | Upgrade
|
| Asset Turnover | - | 0.77 | 0.71 | 0.68 | 0.63 | 0.57 | Upgrade
|
| Inventory Turnover | - | 1.15 | 1.19 | 1.17 | 0.95 | 0.89 | Upgrade
|
| Quick Ratio | - | 0.62 | 0.59 | 0.54 | 0.56 | 0.54 | Upgrade
|
| Current Ratio | - | 1.19 | 1.03 | 0.98 | 1.20 | 1.13 | Upgrade
|
| Return on Equity (ROE) | - | 26.46% | 25.38% | 20.50% | 13.18% | 23.49% | Upgrade
|
| Return on Assets (ROA) | - | 12.17% | 10.69% | 9.52% | 8.14% | 8.11% | Upgrade
|
| Return on Invested Capital (ROIC) | 24.19% | 20.88% | 17.43% | 14.16% | 11.50% | 14.92% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 28.50% | 26.70% | 22.40% | 20.40% | 19.80% | Upgrade
|
| Earnings Yield | 1.54% | 1.75% | 1.88% | 2.39% | 1.64% | 2.91% | Upgrade
|
| FCF Yield | - | 1.80% | 3.22% | 3.45% | 3.38% | 3.88% | Upgrade
|
| Dividend Yield | 0.74% | 1.00% | 1.10% | 1.48% | 1.24% | 1.47% | Upgrade
|
| Payout Ratio | - | 56.67% | 61.30% | 41.21% | 87.10% | 27.03% | Upgrade
|
| Total Shareholder Return | 0.71% | 1.00% | 1.10% | 1.48% | 1.24% | 1.47% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.